The State of Texas Top Legal Officer Files Lawsuit Against Acetaminophen Producers Over Autism Spectrum Allegations

Judicial Proceedings
Ken Paxton, who supports former President Trump campaigning for the United States Senate, alleged pharmaceutical manufacturers of withholding the risks of acetaminophen

Texas Attorney General Paxton is suing the makers of acetaminophen, claiming the companies concealed safety concerns that the medication created to pediatric brain development.

The lawsuit arrives a month after President Donald Trump promoted an unproven link between consuming acetaminophen - alternatively called paracetamol - during pregnancy and autism spectrum disorder in offspring.

Paxton is taking legal action against the pharmaceutical giant, which once produced the medication, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which presently makes it.

In a statement, he said they "misled consumers by profiting off of suffering and marketing drugs ignoring the risks."

The company states there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These manufacturers deceived for years, intentionally threatening countless individuals to line their pockets," the attorney general, a Republican, said.

The manufacturer said in a statement that it was "very worried by the spread of false claims on the reliability of acetaminophen and the likely effects that could have on the health of American women and children."

On its online platform, the company also stated it had "consistently assessed the pertinent research and there is no credible data that shows a proven link between taking paracetamol and autism spectrum disorder."

Organizations acting on behalf of medical professionals and medical practitioners share this view.

The leading OB-GYN organization has stated paracetamol - the key substance in Tylenol - is one of the few options for pregnant women to manage discomfort and elevated temperature, which can present serious health risks if ignored.

"In more than two decades of studies on the consumption of acetaminophen in gestation, not a single reputable study has conclusively proven that the usage of acetaminophen in any period of gestation causes neurodevelopmental disorders in young ones," the group stated.

The court filing references recent announcements from the Trump administration in claiming the drug is potentially dangerous.

Recently, the former president caused concern from public health officials when he advised pregnant women to "struggle intensely" not to use acetaminophen when unwell.

The FDA then issued a notice that physicians should contemplate reducing the use of acetaminophen, while also declaring that "a direct connection" between the drug and autism in young ones has not been proven.

The Health Department head Kennedy, who oversees the FDA, had pledged in spring to undertake "a massive testing and research effort" that would establish the origin of autism in a limited time.

But specialists warned that discovering a sole reason of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of inherited and environmental factors - would not be simple.

Autism is a form of enduring cognitive variation and condition that influences how persons experience and interact with the environment, and is identified using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is seeking federal office - claims Kenvue and J&J "willfully ignored and attempted to silence the research" around paracetamol and autism spectrum disorder.

The case aims to force the firms "destroy any promotional materials" that asserts acetaminophen is reliable for pregnant women.

The court case mirrors the complaints of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in recently.

A federal judge rejected the legal action, declaring research from the plaintiffs' authorities was inconclusive.

Clarence Scott
Clarence Scott

Elara is a passionate esports journalist with over a decade of experience covering major gaming events and trends.